Asia Focus : MakroCare & Qualitix sign Alliance Agreement to extend clinical trials to China and Taiwan

MakroCare, an international clinical services firm providing clinical research services and Qualitix Clinical Research Inc., a Taiwan CRO headquartered in Taipei, announced today the signing of an Alliance Agreement. The agreement means the two companies can offer their wide range of clinical research services to pharmaceutical, biotechnology, and medical devices companies in key territories - Taiwan, China, and Japan.

MakroCare and Qualitix both operate in key strategic regions of Asia and the relationship between the two companies now means that MakroCare can support clients that need services in Taiwan and China, utilizing Qualitix's high quality resources and local know-how.

About Makrocare:
MakroCare, a global clinical services firm, provides clinical research support to pharmaceutical, biotechnology, and medical devices industries. The company offers site selection, patient recruitment, project and clinical data management, clinical monitoring, medical writing, PMS/Pharmacovigilance, biometrics, call centre service, regulatory assistance, and quality assurance. MakroCare has offices in USA (New Jersey, Illinois, Pennsylvania, and California), India (Hyderabad, Mumbai, and New Delhi), Japan (Tokyo), and Europe (Frankfurt).

About Qualitix Clinical Research:
Qualitix Clinical Research Co., Ltd. is a full service CRO based in Taiwan with office in China and focuses on clinical monitoring and site management services for multinational phase II and phase III studies. Qualitix was established in June 2008; however, CRO business was commenced since 1997 under its parent company Genovate Biotechnology Co., Ltd.

For further details, please contact:
Md.Shah Alam Javid
Communications/Media Team
このメールアドレスは、スパムロボットから保護されています。アドレスを確認するにはJavaScriptを有効にしてください